Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-nucleus RNA sequencing identifies a novel tenogenic heterologous differentiation in endometrial carcinosarcomas: implications for diagnosis and tumor classification. | J Pathol | 2026 | 41537454 | PubTator, text mining | PubMed |
| Novel Therapies for Generalized Myasthenia Gravis: Insights Into FcRn and Complement Inhibition. | Am J Ther | 2026 | 41505161 | PubTator, text mining | PubMed |
| Serological testing patterns among individuals newly diagnosed with myasthenia gravis. | J Neurol Sci | 2026 | 41455461 | PubTator, text mining | PubMed |
| Congenital Myasthenic Syndrome: Long-Term Outcomes up to 60 Years, Molecular Characterization, and Eight Novel Variants. | Clin Genet | 2026 | 41451794 | PubTator, text mining | PubMed |
| Syncope as a Presenting Symptom of MuSK-Associated Myasthenia Gravis: A Case Report. | J Child Neurol | 2026 | 41364463 | PubTator, text mining | PubMed |
| Longitudinal treatment patterns in myasthenia gravis: An analysis from the prospective Dutch-Belgian patient registry. | J Neuromuscul Dis | 2026 | 41364382 | PubTator, text mining | PubMed |
| Muscle-specific tyrosine kinase activation by a peptide-based dimerizer is orientation dependent. | Structure | 2026 | 41290004 | PubTator, text mining | PubMed |
| IgA autoantibodies demonstrate a novel mechanism of MuSK myasthenia gravis pathology. | Brain | 2026 | 41147199 | PubTator, text mining | PubMed |
| Aseptic Meningitis Following Rozanolixizumab in a Patient With Refractory Anti-MuSK Positive Myasthenia Gravis: A Case Report. | Neurohospitalist | 2026 | 40949001 | PubTator, text mining | PubMed |
| The Diagnostic Yield of Antiacetylcholine Receptor Antibodies Versus Antimuscle Kinase Antibodies in Ocular Myasthenia Gravis: A Meta-Analysis. | J Neuroophthalmol | 2026 | 40745672 | PubTator, text mining | PubMed |
| On the road to blood biomarkers in myasthenia gravis (MG): Beyond clinical scales. | J Neuromuscul Dis | 2026 | 40560146 | PubTator, text mining | PubMed |
| Eyelid twitching in MuSK-myasthenia gravis. | Acta Neurol Belg | 2026 | 40528144 | PubTator, text mining | PubMed |
| Efgartigimod combined with rituximab helps improve the symptoms and reduce the use of corticosteroids in patients with MuSK antibody-positive MG: a single case report. | Front Immunol | 2025 | 41583497 | PubTator, text mining | PubMed |
| Unilateral Ptosis and Bulbar Symptoms as the Initial Presentation of Late-Onset Acetylcholine Receptor Antibody-Positive Myasthenia Gravis Mimicking Acute Ischemic Stroke in an 82-Year-Old Man. | Cureus | 2025 | 41573440 | PubTator, text mining | PubMed |
| Clinical Features and Outcomes of Ocular Myasthenia Gravis in a Tertiary Philippine Hospital. | Acta Med Philipp | 2025 | 41536333 | PubTator, text mining | PubMed |
| COVID-19-associated delayed-onset MuSK-positive myasthenia gravis presenting solely with respiratory failure: a case report. | Front Immunol | 2025 | 41476989 | PubTator, text mining | PubMed |
| A Case of Anti-MuSK Antibody-positive Myasthenia Gravis Presenting as Limb-Girdle Muscle Atrophy. | Acta Neurol Taiwan | 2025 | 41467263 | PubTator, text mining | PubMed |
| Novel Translational Concept: Axon-to-Muscle Exosomal Signaling as an Emerging Therapeutic Target in Spinal Muscular Atrophy. | Biomedicines | 2025 | 41462890 | PubTator, text mining | PubMed |
| Nipocalimab-aahu in generalised myasthenia gravis: A new Fc receptor-targeted option for antibody-positive patients. | Ibrain | 2025 | 41395452 | PubTator, text mining | PubMed |
| Diagnostic Performance of Three Serological Assays in Myasthenia Gravis: A Prospective Multicentre Study. | Scand J Immunol | 2025 | 41287506 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=6